1. Home
  2. FEAM vs ALXO Comparison

FEAM vs ALXO Comparison

Compare FEAM & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEAM
  • ALXO
  • Stock Information
  • Founded
  • FEAM 2016
  • ALXO 2015
  • Country
  • FEAM United States
  • ALXO United States
  • Employees
  • FEAM N/A
  • ALXO 49
  • Industry
  • FEAM Major Chemicals
  • ALXO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FEAM Industrials
  • ALXO Health Care
  • Exchange
  • FEAM Nasdaq
  • ALXO Nasdaq
  • Market Cap
  • FEAM 78.3M
  • ALXO 63.2M
  • IPO Year
  • FEAM N/A
  • ALXO 2020
  • Fundamental
  • Price
  • FEAM $4.47
  • ALXO $1.22
  • Analyst Decision
  • FEAM Strong Buy
  • ALXO Strong Buy
  • Analyst Count
  • FEAM 2
  • ALXO 6
  • Target Price
  • FEAM $8.25
  • ALXO $3.30
  • AVG Volume (30 Days)
  • FEAM 296.9K
  • ALXO 404.1K
  • Earning Date
  • FEAM 11-13-2025
  • ALXO 11-07-2025
  • Dividend Yield
  • FEAM N/A
  • ALXO N/A
  • EPS Growth
  • FEAM N/A
  • ALXO N/A
  • EPS
  • FEAM N/A
  • ALXO N/A
  • Revenue
  • FEAM N/A
  • ALXO N/A
  • Revenue This Year
  • FEAM N/A
  • ALXO N/A
  • Revenue Next Year
  • FEAM $500.00
  • ALXO N/A
  • P/E Ratio
  • FEAM N/A
  • ALXO N/A
  • Revenue Growth
  • FEAM N/A
  • ALXO N/A
  • 52 Week Low
  • FEAM $2.82
  • ALXO $0.40
  • 52 Week High
  • FEAM $24.84
  • ALXO $2.27
  • Technical
  • Relative Strength Index (RSI)
  • FEAM 45.44
  • ALXO 35.96
  • Support Level
  • FEAM $3.95
  • ALXO $1.13
  • Resistance Level
  • FEAM $4.74
  • ALXO $1.64
  • Average True Range (ATR)
  • FEAM 0.60
  • ALXO 0.14
  • MACD
  • FEAM -0.18
  • ALXO -0.07
  • Stochastic Oscillator
  • FEAM 26.41
  • ALXO 11.04

About FEAM 5E Advanced Materials Inc.

5E Advanced Materials Inc is an exploration stage company focused on becoming a vertically integrated supplier of specialty boron and boron derivative materials whose mission is to enable decarbonization, increase food security, and ensure domestic supply of critical materials. It has a project located in southern California underpinned by a mineral resource that includes boron and lithium, with the boron being contained in a conventional boron mineral known as colemanite. The company seeks to extract and process the minerals into boric acid, boron materials, lithium carbonate, and potentially other co-products on a commercial scale.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: